Document is current
Any future updates will be listed below
-
Authors
Nasser, Mouhamad https://orcid.org/0000-0001-8373-8032
Si-Mohamed, Salim https://orcid.org/0000-0003-0314-4010
Turquier, Ségolène
Traclet, Julie
Ahmad, Kaïs
Philit, François
Bonniaud, Philippe
Chalabreysse, Lara
Thivolet-Béjui, Françoise
Cottin, Vincent https://orcid.org/0000-0002-5591-0955
- License Information
-
More Information
Article History
Received: 25 April 2021
Accepted: 19 September 2021
First Online: 9 October 2021
Declarations
:
: This study was conducted with respect to Declaration of Helsinki report and under Reference Methodology (MR) 004 following the approval by the institutional delegate for the Comité National d’Informatique et Liberté (Reference number 20-067) on 05 March 2020, the committee dedicated to privacy, information technology and civil rights in France. This study was approved by the Research Ethics Committee of Hospices Civils de Lyon.
: Not applicable.
: Not applicable.
: SSM, ST, FP, LC, and FTB have no conflict of interest to disclose. MN reports personal fees from Actelion, AstraZeneca, Boehringer Ingelhium, and Roche outside the submitted work. JT and KA report personal fees from Boehringer Ingelheim and Roche, outside the submitted work. PB reports personal fees from AstraZeneca, Boehringer Ingelheim, Roche, and Sanofi outside the submitted work. VC reports personal fees from Actelion, Bayer, Boehringer Ingelheim, Celgene, Galecto, Galapagos, Novartis, Roche, Sanofi, outside the submitted work.
